Total Payments
$5,814
2024 Payments
$246.82
Companies
35
Transactions
336
Medicare Patients
7,066
Medicare Billing
$448,936
Payment Breakdown by Category
Food & Beverage$5,578 (95.9%)
Education$235.49 (4.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,578 | 330 | 95.9% |
| Education | $235.49 | 6 | 4.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $889.10 | 63 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $496.56 | 27 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $393.44 | 29 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $378.02 | 24 | $0 (2024) |
| PFIZER INC. | $340.68 | 23 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $332.16 | 28 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $331.40 | 20 | $0 (2022) |
| Astellas Pharma US Inc | $283.68 | 8 | $0 (2021) |
| ABIOMED | $255.39 | 2 | $0 (2017) |
| Bayer HealthCare Pharmaceuticals Inc. | $251.73 | 14 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $246.82 | 13 | Boehringer Ingelheim Pharmaceuticals, Inc. ($81.06) |
| 2023 | $357.04 | 16 | PFIZER INC. ($86.12) |
| 2022 | $523.45 | 30 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($117.23) |
| 2021 | $601.16 | 39 | Amgen Inc. ($191.72) |
| 2020 | $238.21 | 14 | Amgen Inc. ($68.42) |
| 2019 | $1,309 | 67 | Amgen Inc. ($193.99) |
| 2018 | $1,178 | 72 | Amgen Inc. ($243.49) |
| 2017 | $1,360 | 85 | ABIOMED ($255.39) |
All Payment Transactions
336 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: DIABETES | ||||||
| 10/29/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 07/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: DIABETES | ||||||
| 07/10/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: Not Applicable | ||||||
| 06/25/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/07/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $26.15 | General |
| Category: Not Applicable | ||||||
| 06/04/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $19.24 | General |
| 05/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: DIABETES | ||||||
| 05/21/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $5.71 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/26/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: DIABETES | ||||||
| 03/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/12/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 11/27/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $12.83 | General |
| Category: Cardiovascular | ||||||
| 11/20/2023 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $35.09 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/19/2023 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $25.83 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/04/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: DIABETES | ||||||
| 08/03/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/28/2023 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/21/2023 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Cardiology | ||||||
| 05/26/2023 | Impulse Dynamics (USA) Inc. | OPTIMIZER (Device), OPTIMIZER | Food and Beverage | Cash or cash equivalent | $28.22 | General |
| Category: Cardiovascular Device | ||||||
| 05/11/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.15 | General |
| Category: Cardiovascular | ||||||
| 05/09/2023 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/03/2023 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,857 | 2,376 | $457,439 | $126,064 |
| 2022 | 22 | 1,875 | 2,456 | $432,529 | $115,325 |
| 2021 | 22 | 1,673 | 2,307 | $365,777 | $109,385 |
| 2020 | 26 | 1,661 | 2,279 | $273,703 | $98,163 |
Total Patients
7,066
Total Services
9,418
Medicare Billing
$448,936
Procedure Codes
97
All Medicare Procedures & Services
97 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 223 | 312 | $75,105 | $27,311 | 36.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 60 | 60 | $42,076 | $19,362 | 46.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 127 | 128 | $85,047 | $17,333 | 20.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 68 | 70 | $31,624 | $8,673 | 27.4% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 27 | 28 | $13,309 | $4,944 | 37.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 111 | 112 | $20,093 | $4,936 | 24.6% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 28 | 112 | $8,253 | $4,640 | 56.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 30 | 32 | $12,403 | $4,354 | 35.1% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 28 | 28 | $5,548 | $4,231 | 76.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 596 | 746 | $25,737 | $4,062 | 15.8% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 38 | 41 | $19,398 | $3,918 | 20.2% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 64 | 64 | $22,783 | $2,977 | 13.1% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 21 | 21 | $7,375 | $2,933 | 39.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 31 | 47 | $6,582 | $2,844 | 43.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 237 | 274 | $42,265 | $2,746 | 6.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $6,521 | $2,703 | 41.5% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 27 | 40 | $9,598 | $1,858 | 19.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 32 | 38 | $3,595 | $1,385 | 38.5% |
| Q9957 | Injection, perflutren lipid microspheres, per ml | Office | 2023 | 23 | 39 | $7,897 | $1,374 | 17.4% |
| 93926 | Ultrasound of one leg arteries or artery grafts | Office | 2023 | 13 | 13 | $2,839 | $1,282 | 45.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 11 | $2,217 | $924.20 | 41.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 13 | $2,179 | $601.20 | 27.6% |
| 85610 | Blood test, clotting time | Office | 2023 | 13 | 105 | $1,009 | $415.80 | 41.2% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 15 | 21 | $3,987 | $256.95 | 6.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 210 | 319 | $76,764 | $27,603 | 36.0% |
About Dr. Patrick Chan-Lam, MD
Dr. Patrick Chan-Lam, MD is a Cardiovascular Disease healthcare provider based in Williamsville, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205807575.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Chan-Lam, MD has received a total of $5,814 in payments from pharmaceutical and medical device companies, with $246.82 received in 2024. These payments were reported across 336 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($5,578).
As a Medicare-enrolled provider, Chan-Lam has provided services to 7,066 Medicare beneficiaries, totaling 9,418 services with total Medicare billing of $448,936. Data is available for 4 years (2020–2023), covering 97 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Williamsville, NY
- Active Since 01/27/2006
- Last Updated 02/07/2011
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1205807575
Products in Payments
- Repatha (Biological) $701.70
- ELIQUIS (Drug) $443.73
- LifeVest (Device) $378.02
- ENTRESTO (Drug) $363.89
- XARELTO (Drug) $331.40
- JARDIANCE (Drug) $302.24
- Impella (Device) $255.39
- Adempas (Drug) $233.81
- PRADAXA (Drug) $194.32
- MULTAQ (Drug) $193.05
- Corlanor (Drug) $158.23
- Vascepa (Drug) $136.18
- VYNDAQEL (Drug) $133.19
- TEGSEDI (Drug) $108.71
- Claria MRI (Device) $95.18
- CHANTIX (Drug) $83.09
- BRILINTA (Drug) $78.76
- WATCHMAN FLX (Device) $78.57
- Carto 3 System (Device) $76.63
- VERQUVO (Drug) $74.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Williamsville
Dr. Chee Kim, Md, MD
Cardiovascular Disease — Payments: $264,173
Cardiovascular Disease $264,173
Dr. Jai Wadhwani, M.d, M.D
Cardiovascular Disease — Payments: $254,917
Cardiovascular Disease $254,917
Dr. Donald Switzer, Md, MD
Cardiovascular Disease — Payments: $43,807
Cardiovascular Disease $43,807
Dr. Ranjan Bhayana, Md, MD
Cardiovascular Disease — Payments: $37,934
Cardiovascular Disease $37,934
Brian Riegel, Md, MD
Cardiovascular Disease — Payments: $34,847
Cardiovascular Disease $34,847
Richard Corbelli, Md, MD
Cardiovascular Disease — Payments: $24,647
Cardiovascular Disease $24,647